Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Dipayan Roy, Anupama Modi, Purvi Purohit, Manoj Khokhar, Manu Goyal, Shailja Sharma, Puneet Setia, Antonio Facciorusso & Praveen Sharma. (2022) Growth Differentiation Factor-15 as a Candidate Biomarker in Gynecologic Malignancies: A Meta-analysis. Cancer Investigation 40:10, pages 901-910.
Read now
Read now
Qurat ul Ain, Shan Muhammad, Yang Hai & Li Peiling. (2022) The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours. Journal of Obstetrics and Gynaecology 42:8, pages 3441-3449.
Read now
Read now
Juan Yang, Zhuandi Gong, Xiaoyun Shen, Shengju Bai, Xiaoqiang Bai & Suocheng Wei. (2021) FSH receptor binding inhibitor depresses carcinogenesis of ovarian cancer via decreasing levels of K-Ras, c-Myc and FSHR. Animal Biotechnology 32:1, pages 84-91.
Read now
Read now
Articles from other publishers (81)
Azza Habel, Xu Weili, Mariem Hadj Ahmed, Mouna Stayoussef, Hanen Bouaziz, Mouna Ayadi, Amel Mezlini, Anis Larbi & Basma Yaacoubi-Loueslati. (2023) Immune checkpoints as potential theragnostic biomarkers for epithelial ovarian cancer. The International Journal of Biological Markers 38:3-4, pages 203-213.
Crossref
Crossref
E. M. Kagirova, R. I. Khusainova & I. R. Minniakhmetov. (2023) Diagnosis and treatment of ovarian cancer in the light of modern molecular genetic achievements. Siberian journal of oncology 22:5, pages 118-133.
Crossref
Crossref
Yang Fan, Long Wang, Xuechuang Han, Hongyun Ma, Na Zhang & Lina She. (2023) LncRNA ASB16-AS1 accelerates cellular process and chemoresistance of ovarian cancer cells by regulating GOLM1 expression via targeting miR-3918. Biochemical and Biophysical Research Communications 675, pages 1-9.
Crossref
Crossref
Jin‐Qi Sun, Shi‐Nan Wu, Zheng‐Lin Mou, Jia‐Yi Wen, Hong Wei, Jie Zou, Qing‐Jian Li, Zhao‐Lin Liu, San Hua Xu, Min Kang, Qian Ling, Hui Huang, Xu Chen, Yi‐Xin Wang, Xu‐Lin Liao, Gang Tan & Yi Shao. (2023) Prediction model of ocular metastasis from primary liver cancer: Machine learning‐based development and interpretation study. Cancer Medicine 12:20, pages 20482-20496.
Crossref
Crossref
Pan Wang, Jihong Ma, Wenjing Li, Qilong Wang, Yinan Xiao, Yuening Jiang, Xiaoyang Gu, Yu Wu, Suwei Dong, Hongyan Guo & Mo Li. (2023) Profiling the metabolome of uterine fluid for early detection of ovarian cancer. Cell Reports Medicine 4:6, pages 101061.
Crossref
Crossref
Aleksandra Englisz, Marta Smycz-Kubańska & Aleksandra Mielczarek-Palacz. (2023) Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer. Diagnostics 13:10, pages 1714.
Crossref
Crossref
Alba Galan, Arturo Papaluca, Ali Nejatie, Emad Matanes, Fouad Brahimi, Wenyong Tong, Ibrahim Yaseen Hachim, Amber Yasmeen, Euridice Carmona, Kathleen Oros Klein, Sonja Billes, Ahmed E. Dawod, Prasad Gawande, Anna Milik Jeter, Anne-Marie Mes-Masson, Celia M. T. Greenwood, Walter H. Gotlieb & H. Uri Saragovi. (2023) GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer. Frontiers in Oncology 13.
Crossref
Crossref
Sourav Chakraborty, Priti S. Shenoy, Megha Mehrotra, Pratham Phadte, Prerna Singh, Bharat Rekhi & Pritha Ray. (2023) Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics. Diagnostics 13:4, pages 713.
Crossref
Crossref
洁 严. (2023) Research Progress of the Relationship between Peripheral Blood Indexes and the Diagnosis, Treatment and Prognosis of Ovarian Cancer. Advances in Clinical Medicine 13:11, pages 17362-17373.
Crossref
Crossref
Kacper Szczepski, Inas Al-Younis, Manel Dhahri, Joanna Izabela Lachowicz, Zeyad A. Al-Talla, Hanan Almahasheer, Noura Alasmael, Mahbuba Rahman, Abdul-Hamid Emwas, Łukasz Jaremko & Mariusz Jaremko. 2023. Metabolomics. Metabolomics
173
198
.
Saba Wani, Humaira, Iqra Farooq, Shafat Ali, Muneeb U. Rehman & Azher Arafah. 2023. Proteomics. Proteomics
121
153
.
Elena Ioana Braicu, Catherine Linn Krause, Uwe Torsten, Herbert Mecke, Rolf Richter, Lars Hellmeyer, Malgorzata Lanowska, Bodo Müller, Elisa Koch, Janine Boenneß-Zaloum, Kerstin Ames, Radoslav Chekerov, Kati Hasenbein, Mathias Zimmermann, Mandy Mangler, Frank Chen, Rudolf Tauber & Jalid Sehouli. (2022) HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients. BMC Cancer 22:1.
Crossref
Crossref
Yan Li, Juan Wang, Fang Wang, Wenyu Chen, Chengzhen Gao & Jianhua Wang. (2021) RNF144A suppresses ovarian cancer stem cell properties and tumor progression through regulation of LIN28B degradation via the ubiquitin-proteasome pathway. Cell Biology and Toxicology 38:5, pages 809-824.
Crossref
Crossref
Lucia Manganaro, Veronica Celli, Valentina Viggiani, Elena Berardelli, Teresa Granato, Sara Tartaglione, Antonella Farina, Carlo Catalano, Antonio Angeloni & Emanuela Anastasi. (2022) CT imaging phenotypes linked to CA125 and HE4 biomarkers are highly predictive in discriminating between hereditary and sporadic ovarian cancer patients. Tumor Biology 44:1, pages 171-185.
Crossref
Crossref
Naoki Sumitani, Kyoso Ishida, Kenjiro Sawada, Tadashi Kimura, Yasufumi Kaneda & Keisuke Nimura. (2022) Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing. Cancers 14:15, pages 3580.
Crossref
Crossref
Hui Xu, Yan Tang, Lu Liu, Jie Yan & Li Qin. (2022) Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer
Correlates with Worse Prognosis and Cancer Progression. Hormone and Metabolic Research 54:07, pages 481-488.
Crossref
Crossref
Jinbiao Han & Xia Hu. (2022) IGF2BP3‑stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells. Molecular Medicine Reports 26:1.
Crossref
Crossref
Hasan Turan, Salvatore Giovanni Vitale, Ilker Kahramanoglu, Luigi Della Corte, Pierluigi Giampaolino, Asli Azemi, Sinem Durmus, Veysel Sal, Nedim Tokgozoglu, Tugan Bese, Macit Arvas, Fuat Demirkiran, Remise Gelisgen, Sennur Ilvan & Hafize Uzun. (2022) Diagnostic and prognostic role of TFF3, Romo-1, NF-кB and SFRP4 as biomarkers for endometrial and ovarian cancers: a prospective observational translational study. Archives of Gynecology and Obstetrics 306:6, pages 2105-2114.
Crossref
Crossref
Louise Faaborg, Rikke Fredslund Andersen, Marianne Waldstrøm, Jon Røikjær Henriksen, Parvin Adimi, Anders Jakobsen & Karina Dahl Steffensen. (2022) Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer. Cancers 14:7, pages 1766.
Crossref
Crossref
Nan Mao, Hu Li, Hui Yang, Jianfen Su, Zhimin Liang & Guansheng He. (2022) PTPN18 Stimulates the Development of Ovarian Cancer by Activating the PI3K/AKT Signaling. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-7.
Crossref
Crossref
Federica Farinella, Mario Merone, Luca Bacco, Adriano Capirchio, Massimo Ciccozzi & Daniele Caligiore. (2022) Machine Learning analysis of high-grade serous ovarian cancer proteomic dataset reveals novel candidate biomarkers. Scientific Reports 12:1.
Crossref
Crossref
Dina Mikdadi, Kyle A. O’Connell, Philip J. Meacham, Madeleine A. Dugan, Michael O. Ojiere, Thaddeus B. Carlson & Juergen A. Klenk. (2022) Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery. Cancer Biomarkers 33:2, pages 173-184.
Crossref
Crossref
Raul Gomez, Miguel Á. Tejada, Víctor Rodríguez-García, Octavio Burgués, Ana I. Santos-Llamas, Andrea Martínez-Massa, Antonio Marín-Montes, Juan J. Tarín & Antonio Cano. (2022) Histological Grade and Tumor Stage Are Correlated with Expression of Receptor Activator of Nuclear Factor Kappa b (Rank) in Epithelial Ovarian Cancers. International Journal of Molecular Sciences 23:3, pages 1742.
Crossref
Crossref
Lu Mao, Yong Tang, Ming‐jing Deng, Chun‐tao Huang, Dong Lan, Wen‐Zheng Nong, Li Li & Qi Wang. (2022) A combined biomarker panel shows improved sensitivity and specificity for detection of ovarian cancer. Journal of Clinical Laboratory Analysis 36:2.
Crossref
Crossref
Bimal Prasad Jit, Biswajita Padhan & Ashok Sharma. 2022. Bio-Nano Interface. Bio-Nano Interface
161
175
.
Ece Gumusoglu-Acar & Tuba Gunel. 2022. Advances in Diagnosis and Management of Ovarian Cancer. Advances in Diagnosis and Management of Ovarian Cancer
27
42
.
Xiaolin Xu, Shuqin Yu, Xiaoyuan Liu & Ying Feng. (2021) Ultrasound-Targeted Microbubble Destruction-Mediated Inhibition of Livin Expression Accelerates Ovarian Cancer Cell Apoptosis. Genetics Research 2021, pages 1-7.
Crossref
Crossref
Han Zhang, Yijun Wu, Hao Li, Liping Sun & Xiangkai Meng. (2021) Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response. Cancer Cell International 21:1.
Crossref
Crossref
Louise Faaborg, Rikke Fredslund Andersen, Marianne Waldstrøm, Estrid Høgdall, Claus Høgdall, Parvin Adimi, Anders Jakobsen & Karina Dahl Steffensen. (2021) Analysis of HOXA9 methylated ctDNA in ovarian cancer using sense-antisense measurement. Clinica Chimica Acta 522, pages 152-157.
Crossref
Crossref
Dai Zhang, Yiche Li, Si Yang, Meng Wang, Jia Yao, Yi Zheng, Yujiao Deng, Na Li, Bajin Wei, Ying Wu, Zhen Zhai, Zhijun Dai & Huafeng Kang. (2021) Identification of a glycolysis‐related gene signature for survival prediction of ovarian cancer patients. Cancer Medicine 10:22, pages 8222-8237.
Crossref
Crossref
Louise Faaborg, Anders Jakobsen, Marianne Waldstrøm, Christina B Petersen, Rikke F Andersen & Karina D Steffensen. (2021) HOXA9-methylated DNA as a diagnostic biomarker of ovarian malignancy. Biomarkers in Medicine 15:15, pages 1309-1317.
Crossref
Crossref
Brittany P. Rickard, Christina Conrad, Aaron J. Sorrin, Mustafa Kemal Ruhi, Jocelyn C. Reader, Stephanie A. Huang, Walfre Franco, Giuliano Scarcelli, William J. Polacheck, Dana M. Roque, Marcela G. del Carmen, Huang-Chiao Huang, Utkan Demirci & Imran Rizvi. (2021) Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response. Cancers 13:17, pages 4318.
Crossref
Crossref
Naba Kumar Das & Saptadip Samanta. (2021) The promising oncostatic effects of melatonin against ovarian cancer. World Journal of Current Medical and Pharmaceutical Research, pages 85-93.
Crossref
Crossref
Jia Wang, Haonan Li, Liang Wang, Jing Zhang, Man Li, Liang Qiao, Jun Zhang, Likun Liu, Cuili Zhang, Jingchun Gao & Weiling Li. (2021) Transcriptomic Analyses Reveal B-Cell Translocation Gene 2 as a Potential Therapeutic Target in Ovarian Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Sebastjan Merlo, Nikola Besic, Eva Drmota & Nina Kovacevic. (2021) Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer. Radiology and Oncology 55:3, pages 341-346.
Crossref
Crossref
Meiyin Zhang, Ye Xu, Yongjian Zhang, Bing Li & Ge Lou. (2021) Circular RNA circE2F2 promotes malignant progression of ovarian cancer cells by upregulating the expression of E2F2 protein via binding to HuR protein. Cellular Signalling 84, pages 110014.
Crossref
Crossref
Kate McKendry, Stephen Duff, Yanmei Huang, Mostafa Redha, Áine Scanlon, Feras Abu Saadeh, Noreen Gleeson, John O’Leary, Lucy Norris & Sharon O’Toole. (2021)
The value of human epididymis 4,
D
‐dimer, and fibrinogen compared with CA 125 alone in triaging women presenting with pelvic masses: a retrospective cohort study
. Acta Obstetricia et Gynecologica Scandinavica 100:7, pages 1239-1247.
Crossref
Crossref
Mihaela Raluca Radu, Alina Prădatu, Florentina Duică, Romeo Micu, Sanda Maria Creţoiu, Nicolae Suciu, Dragoş Creţoiu, Valentin Nicolae Varlas & Viorica Elena Rădoi. (2021) Ovarian Cancer: Biomarkers and Targeted Therapy. Biomedicines 9:6, pages 693.
Crossref
Crossref
Christos Iavazzo, Alexandros Fotiou, Victoria Psomiadou, Sofia Lekka, Dimitrios Katsanos & John Spiliotis. (2021) Small Bowel PCI Score as a Prognostic Factor of Ovarian Cancer Patients Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), a Retrospective Analysis of 130 Patients. Indian Journal of Surgical Oncology 12:2, pages 258-265.
Crossref
Crossref
Sherif B. Elsherif, Priya R. Bhosale, Chandana Lall, Christine O. Menias, Malak Itani, Kristina A. Butler & Dhakshinamoorthy Ganeshan. (2021) Current update on malignant epithelial ovarian tumors. Abdominal Radiology 46:6, pages 2264-2280.
Crossref
Crossref
Shuvolina Mukherjee, Karin Sundfeldt, Carl A. K. Borrebaeck & Magnus E. Jakobsson. (2021) Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers. Proteomes 9:2, pages 25.
Crossref
Crossref
Joohyun Ryu & Stefani N. Thomas. (2021) Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer. Molecules 26:9, pages 2674.
Crossref
Crossref
Yan Li, Fan-fan Huo, Ying-ying Wen & Miao Jiang. (2021) Screening and Identification of an Immune-Associated lncRNA Prognostic Signature in Ovarian Carcinoma: Evidence from Bioinformatic Analysis. BioMed Research International 2021, pages 1-13.
Crossref
Crossref
Kang Yu, Jing Tang, Jie-Li Wu, Biao Li, Shi-Nan Wu, Meng-Yao Zhang, Qiu-Yu Li, Li-Juan Zhang, Yi-Cong Pan, Qian-Min Ge, Hui-Ye Shu & Yi Shao. (2021) Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125. World Journal of Diabetes 12:2, pages 158-169.
Crossref
Crossref
Qin Chen, Yan Feng, Wenwen Wang, Weiguo Lv & Baohua Li. (2021) Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma. Scientific Reports 11:1.
Crossref
Crossref
Isabel J. Dionísio de Sousa, Ana Isabel Cunha, Inês A. Saraiva, Raquel V. Portugal, Etel R.P. Gimba, Marcos Guimarães, Hugo Prazeres, José M. Lopes, Paula Soares & Raquel T. Lima. (2021) LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer. Pathobiology 88:6, pages 400-411.
Crossref
Crossref
Wenjie Hou & Yueming Zhang. (2021) Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-184. Pathology - Research and Practice 217, pages 153275.
Crossref
Crossref
Manuel Torralba, Rossella Farra, Marianna Maddaloni, Mario Grassi, Barbara Dapas & Gabriele Grassi. (2020) Drugs Repurposing in High-Grade Serous Ovarian Cancer. Current Medicinal Chemistry 27:42, pages 7222-7233.
Crossref
Crossref
Devesh Sharma & Anjali Vinocha. (2020) Benign Ovarian Cysts with Raised CA-125 Levels: Do We Need to Evaluate the Fallopian Tubes?. Journal of Laboratory Physicians 12:04, pages 276-280.
Crossref
Crossref
Pia Leandersson, Anna Åkesson, Ingrid Hedenfalk, Susanne Malander & Christer Borgfeldt. (2020) A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients. PLOS ONE 15:10, pages e0240418.
Crossref
Crossref
Chun‐Na Liu & Hai‐Yan Zhang. (2020) Serum lncRNA LOXL1‐AS1 is a diagnostic and prognostic marker for epithelial ovarian cancer. The Journal of Gene Medicine 22:10.
Crossref
Crossref
Marcel Bäumler, Delphine Gallant, René Druckmann & Walther Kuhn. (2020) Ultrasound screening of ovarian cancer. Hormone Molecular Biology and Clinical Investigation 41:3.
Crossref
Crossref
Khalid El Bairi, Said Afqir & Mariam Amrani. (2020) Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?. Current Drug Targets 21:10, pages 1026-1033.
Crossref
Crossref
Xue-Ying Ren, Wei-Bin Yang & Yun Tian. (2020) Overexpression of long noncoding RNA PTPRG-AS1 is associated with poor prognosis in epithelial ovarian cancer. Revista da Associação Médica Brasileira 66:7, pages 948-953.
Crossref
Crossref
Xue Li, Longjun Zhao & Tengteng Meng. (2020) Upregulated CXCL14 is associated with poor survival outcomes and promotes ovarian cancer cells proliferation. Cell Biochemistry and Function 38:5, pages 613-620.
Crossref
Crossref
Derya KILIÇ, Hakan YETİMALAR, Mehmet KÖSEOĞLU & Gülcan SAĞLAM. (2020) Assessment of diagnostic value of ‘Human Epididymis Factor 4 (HE4)’ in women with adnexal masses. Pamukkale Medical Journal.
Crossref
Crossref
Wen-Ling Lee & Peng-Hui Wang. (2020) Aberrant sialylation in ovarian cancers. Journal of the Chinese Medical Association 83:4, pages 337-344.
Crossref
Crossref
Aasa Shimizu, Kenjiro Sawada & Tadashi Kimura. (2020) Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer. Cells 9:4, pages 814.
Crossref
Crossref
Anh M. Tran, Ghanbar Mahmoodi Chalbatani, Lea Berland, Mireia Cruz De los Santos, Priyank Raj, Seyed Amir Jalali, Elahe Gharagouzloo, Cristina Ivan, Mihnea P. Dragomir & George A. Calin. (2020) A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Mei Zhang, Ling Sha, Ning Hou, Chuanbing Shi & Lin Tan. (2020) High expression of sperm-associated antigen 5 correlates with poor survival in ovarian cancer. Bioscience Reports 40:2.
Crossref
Crossref
Wei‐Lei Yang, Zhen Lu, Jing Guo, Bryan M. Fellman, Jing Ning, Karen H. Lu, Usha Menon, Makoto Kobayashi, Samir M. Hanash, Joseph Celestino, Steven J. Skates & Robert C. BastJrJr. (2019) Human epididymis protein 4 antigen‐autoantibody complexes complement cancer antigen 125 for detecting early‐stage ovarian cancer. Cancer 126:4, pages 725-736.
Crossref
Crossref
Kun Ji, Xiaohua Wang, Anqi Zhang & Hongwei Wen. (2020) Prognostic value of microRNA-21 in epithelial ovarian carcinoma. Medicine 99:52, pages e23849.
Crossref
Crossref
Ninad Katdare, Aditi Bhatt & Olivier Glehen. 2020. Pathology of Peritoneal Metastases. Pathology of Peritoneal Metastases
251
279
.
Dmitriy W. Gutkin, Michael R. Shurin, Mounia Alaoui El Azher, Galina V. Shurin, Liudmila Velikokhatnaya, Denise Prosser, Namhee Shin, Francesmary Modugno, Paul Stemmer, Esther Elishaev & Anna Lokshin. (2019) Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary. Cancer Biomarkers 26:4, pages 471-479.
Crossref
Crossref
Vincent Dochez, Hélène Caillon, Edouard Vaucel, Jérôme Dimet, Norbert Winer & Guillaume Ducarme. (2019) Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. Journal of Ovarian Research 12:1.
Crossref
Crossref
Thingreila Muinao, Hari Prasanna Deka Boruah & Mintu Pal. (2019) Multi-biomarker panel signature as the key to diagnosis of ovarian cancer. Heliyon 5:12, pages e02826.
Crossref
Crossref
Ruth Hüttenhain, Meena Choi, Laura Martin de la Fuente, Kathrin Oehl, Ching-Yun Chang, Anne-Kathrin Zimmermann, Susanne Malander, Håkan Olsson, Silvia Surinova, Timothy Clough, Viola Heinzelmann-Schwarz, Peter J. Wild, Daniela M. Dinulescu, Emma Niméus, Olga Vitek & Ruedi Aebersold. (2019) A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer. Molecular & Cellular Proteomics 18:9, pages 1836-1850.
Crossref
Crossref
Marisol Salgado-Albarrán, Rodrigo González-Barrios, Lissania Guerra-Calderas, Nicolás Alcaraz, Thalía Estefanía Sánchez-Correa, Clementina Castro-Hernández, Yesennia Sánchez-Pérez, Elena Aréchaga-Ocampo, Alejandro García-Carrancá, David Cantú de León, Luis A. Herrera, Jan Baumbach & Ernesto Soto-Reyes. (2019) The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer. Oncogenesis 8:8.
Crossref
Crossref
Hongyu Deng, Ming Chen, Xinwu Guo, Jianfu Heng, Xunxun Xu, Limin Peng, Hui Jiang, Guoli Li, Julia X. Day, Jinliang Li, Dongyong Shan, Yinghua Li, Yanjie Zhou, Bin Liu, Lizhong Dai, Xiaochun Wang & Jun Wang. (2019)
Comprehensive analysis of serum tumor markers and
BRCA1/2
germline mutations in Chinese ovarian cancer patients
. Molecular Genetics & Genomic Medicine 7:6.
Crossref
Crossref
Yuanyuan Zhong, Yingying Wang, Jianfei Huang, Xiangyu Xu, Weidong Pan, Sainan Gao, Yuquan Zhang & Min Su. (2019) Association of hCG and LHCGR expression patterns with clinicopathological parameters in ovarian cancer. Pathology - Research and Practice 215:4, pages 748-754.
Crossref
Crossref
Amy P.N. Skubitz, Kristin L.M. Boylan, Kate Geschwind, Qing Cao, Timothy K. Starr, Melissa A. Geller, Joseph Celestino, Robert C. BastJr.Jr., Karen H. Lu & Joseph S. Koopmeiners. (2019) Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection. Cancer Prevention Research 12:3, pages 171-184.
Crossref
Crossref
Todd Klein, Wei Wang, Lina Yu, Kai Wu, Kristin L.M. Boylan, Rachel Isaksson Vogel, Amy P.N. Skubitz & Jian-Ping Wang. (2019) Development of a multiplexed giant magnetoresistive biosensor array prototype to quantify ovarian cancer biomarkers. Biosensors and Bioelectronics 126, pages 301-307.
Crossref
Crossref
Tatsuyuki Chiyoda, Ai Dozen, Keiko Saotome, Yoshiko Nanki & Daisuke Aoki. 2019. Biomarkers in Cancer Therapy. Biomarkers in Cancer Therapy
133
150
.
Kevin M. Elias, Jing Guo & Robert C. BastJr.Jr.. (2018) Early Detection of Ovarian Cancer. Hematology/Oncology Clinics of North America 32:6, pages 903-914.
Crossref
Crossref
Joana Assis, Deolinda Pereira, Augusto Nogueira & Rui Medeiros. 2018. Ovarian Cancer - From Pathogenesis to Treatment. Ovarian Cancer - From Pathogenesis to Treatment.
Suchitra Kumari. (2018) Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review. Indian Journal of Clinical Biochemistry 33:4, pages 382-386.
Crossref
Crossref
Mei LinBairong XiaLing QinHong ChenGe Lou. (2018) S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p. DNA and Cell Biology 37:5, pages 491-500.
Crossref
Crossref
Wentao Yu, Ran Cui, Hong Qu, Chongdong Liu, Haiteng Deng & Zhenyu Zhang. (2018) Expression and prognostic value of CLIC1 in epithelial ovarian cancer. Experimental and Therapeutic Medicine.
Crossref
Crossref
Ben Davidson. 2018. Serous Effusions. Serous Effusions
49
73
.
Ching-Wei Lin, Hailing Yang, Stephen R. Sanchez, Weiqun Mao, Lan Pang, Kathleen M. Beckingham, Robert C. BastJr.Jr. & R. Bruce Weisman. (2017) In Vivo Optical Detection and Spectral Triangulation of Carbon Nanotubes. ACS Applied Materials & Interfaces 9:48, pages 41680-41690.
Crossref
Crossref
Stella Capriglione, Daniela Luvero, Francesco Plotti, Corrado Terranova, Roberto Montera, Giuseppe Scaletta, Teresa Schirò, Gianmarco Rossini, Pierluigi Benedetti Panici & Roberto Angioli. (2017) Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature. Medical Oncology 34:9.
Crossref
Crossref